Chief Scientist
Wenqiang Yu, Ph.D.
●Chief Scientist weNational "973" Chirongwa;
●Kunyanya-akagadzwa Purofesa weChang Jiang Scholars Chirongwa;
●PI, Center for Epigenetics, Institute of Biomedical Sciences Fudan University;
●Akanyanya-akagadzwa Muongorori uye Chiremba Mutariri weFudan University;
●Mutungamiriri weMethylation Marker Nyanzvi Komiti yeTumor Marker Committee yeChinese Anti-Cancer Association.
Muna 1989, akapedza kudzidza paFourth Military Medical University uye akawana Bachelor's Degree in Medicine;
Muna 2001, akagamuchira Dhigirii rake reDoctorate kubva kuFourth Military Medical University;
Kubva 2001-2004, akawana Postdoctoral muDhipatimendi Rekuvandudza uye Genetics, Uppsala University, Sweden;
Kubva 2004-2007, akawana Postdoctoral muHopkins University School of Medicine, United States;
Parizvino, Muzvinafundo Yu ndiye PI uye anotsvagisa shamwari yeInstitute of Biomedical Sayenzi yeFudan University, uye Executive Mutevedzeri weMukuru weInstitute of Genomics uye Epigenomics yeFudan University.Zvaakaita patsvagiridzo yake zvakaburitswa mumapepanhau epamusoro edzidzo epasi rese sekuti,Nature, Nature GeneticsuyeJAMA.
yakanyorwa mumajenari epamusoro edzidzo epasi rose seNature, Nature Genetics neJAMA, ine simba repamusoro-soro remapoinzi makumi matatu nemasere.
CEO
Lin Hua
Bachelor of Economics yeShanghai JiaoYunivhesiti yeTong.Akashanda seMutungamiriri Mukuru weDhipatimendi reKambani yeGuosen Securities, shamwari yeXIANGDU CAPITAL, muvambi weCHOBE CAPITAL.Semutungamiri weboka, akasimudzira kudyara makambani akati wandei akabudirira.
ObiO(688238): CGT CDMO mugadziri ane hukuru hukuru;
Novoprotein (688137): mupi wezvinhu zvakasvibirira anotarisa kune recombinant protein;
Leadsynbio: inotungamira kambani mukugadzira biology;
SinoBay: yakanangwa bundu kurapwa mabhizinesi
Quectel (603236): bhizinesi rakakura kwazvo pasirese repasirese
XinpelTek: tarisa pane isina waya PA RF chip bhizinesi;
DGene: tarisa pane 3D dhijitari bhizinesi
Vhidhiyo ++: unicorn bhizinesi munzvimbo yeAI
Neanopfuura makore gumi mumusika mukuru, Ms Hua akawana ruzivo rwakakura mukutarisira kwemakambani nekudyara.
R&D Director
Wei Li, Ph.D.
Chiremba Li akashanda seAssociate Researcher muInstitute of Biological Science Fudan University kwemakore gumi.Akatungamira mapurojekiti matatu ekutsvagisa anosanganisira National Natural Science Foundation yekuChina,iyo yakazvimirira yekutsvagisa Chirongwa chekuunza matarendauye etc.Akatorawo mapurojekiti akati wandei enyika, kusanganisira National 973 Project, Key Project yeNational Natural Science Foundation zvichingodaro.Akaburitsa mapepa gumi nematanhatu eSCI semunyori wekutanga kana munyori anowirirana muGenome Research, eBiomedicine, Nuclear Acid Research uye etc.(Aggregate Impact Factor 158.97).
Zvikuru zvekutsvaga zvaunofarira:
1. Kubudirira kwe epigenetic algorithms uye akawanda-omics zvidzidzo zve tumor pathogenesis.Imwe base base pair inogadzirisa iyo yese genome-wide DNA methylation sequencing yekuongorora chikuva (WGPS algorithm) yakavambwa munhanho yekutanga.Ipapo yekutanga yakazara genome-yakafara DNA methylation mepu yemasero echiropa chemunhu yawanikwa.Zvichakadaro, akapa nzira nyowani yebundu suppressor gene kunyarara mune epigenetics maonero.
2. Skirini yakajairika biomarkers yehuipi maitiro mumhando dzegomarara dzakawanda nedata-zhinji-omics.Zvichienderana nemaitiro eWGPS, takaongorora akakosha hypermethylation mamaki pakati pemamota uye akajairwa.
3. Tsvakurudzo pamusoro pepathogenesis ye gene transcriptional activation neNamiRNA: Kirasi ye nuclear miRNA, iyo yatakatumidza kuti NamiRNA (Nuclear Activating miRNA).
Medical R&D Injiniya
Meigui Wang, Ph.D.
Chiremba Wang vakagashira Ph.D yavo.dhigirii kubva kuSouth Medical University muna 2019. Akaenderera mberi nedzidzo yake yekugara muChechitatu Affiliated Hospital yeSun Yat-sen University(2019-2021).Chido chake chekiriniki ndechekuongororwa uye kurapwa kwegomarara remusoro nemutsipa senge laryngeal cancer uye nasopharyngeal carcinoma.Zvido zvake zvekutsvagisa zvinotarisa pakuongororwa kwekutanga kwenasopharyngeal carcinoma.
Medical R&D Injiniya
Yaping Dong, Ph.D.
Chiremba Dong vakawana Ph.D.dhigirii remishonga yekiriniki kubva kuFujian Medical University muna 2020, uye akaita tsvakiridzo yepashure-kwechiremba muFudan University Shanghai Cancer centre kubva muna 2020 kusvika 2022. Semutori wechikamu mukuru, akapinda maProjekti eNyika akati wandei, kusanganisira Ministry of Science and Technology Key Program ye “ Yakakosha New Drugs Development”, iyo National Natural Science Foundation yeChina uye zvichingodaro.Akaburitsa akati wandei emhando yepamusoro mapepa muActa Pharmaceutica Sinica B, Acta Pharmacologica Sinica uye Radiation Oncology.